Royalty Pharma 

Quarterly Financials

Values in thousands2026-03-312025-12-312025-09-302025-06-30
Revenue
$631,000
$621,990
$609,291
$578,665
Gross Profit
629,405
621,990
609,291
578,665
EBITDA
633,652
451,280
525,052
159,303
EBIT
632,481
450,084
523,775
209,799
Net Income
295,000
214,205
288,217
30,176
Net Change In Cash
631,000
621,990
609,291
578,665
Free Cash Flow
760,539
827,148
702,615
363,984
Cash
586,395
619,000
938,944
631,908
Basic Shares
559,611
559,611
559,611
562,298

Annual Financials

Values in thousands2025-12-312024-12-312023-12-312022-12-31
Revenue
$2,378,193
$2,263,576
$2,354,554
$2,237,215
Gross Profit
2,378,193
2,263,576
2,354,554
2,237,215
EBITDA
1,635,708
1,556,325
1,887,275
423,695
EBIT
1,631,856
1,292,444
1,492,150
418,025
Net Income
770,947
858,983
1,134,834
42,832
Net Change In Cash
2,378,193
2,263,576
2,354,554
2,237,215
Cost of Revenue
169,703
Free Cash Flow
2,489,823
2,768,986
2,987,802
4,185,132
Cash
618,696
929,026
477,010
1,710,751
Basic Shares
559,611
594,000
602,900
564,931

Earnings Calls

QuarterEPS
2026-03-31
$1.30
2025-12-31
$1.47
2025-09-30
$1.17
2025-06-30
$1.14